Schizochytrium on the European supplement market
Most ingredient pages tell you what Schizochytrium is. This one shows how the European supplement market actually uses it — who sells it, who advertises it, and at what price.
RavenBI Market Intelligence · measured 25 Oct 2026 · observed, not estimated. Ad counts are active creatives in Meta's public Ad Library; product and price data come from public listings across the EU and US. Figures change weekly.
RavenBI tracks 215 Schizochytrium products from 125 brands across the EU and US. 3 brands advertise it on Meta right now, and new-ad activity held roughly steady in the last 30 days. BG shows the heaviest advertising, while Germany has the largest shelf. The median EU shelf price sits around €33.
New Schizochytrium ads launched per month on Meta — last 6 months.
How brands use Schizochytrium, market by market
Products and brands that sell it, active ads and brands that advertise it, and the median shelf price — per market.
| Market | Products | Brands selling | Active ads | Brands advertising | Median price |
|---|---|---|---|---|---|
| Germany | 90 | 47 | — | — | €33.90 |
| United Kingdom | 34 | 21 | — | — | £26.18 |
| France | 10 | 9 | 1 | 1 | €36.00 |
| Italy | 15 | 9 | — | — | €31.90 |
| Spain | 14 | 11 | — | — | €25.97 |
| Romania | 7 | 5 | 1 | 1 | 149.99 RON |
| United States | 2 | 2 | — | — | — |
| Austria | 13 | 7 | — | — | €38.90 |
Who is on the shelf right now
Top brands by number of Schizochytrium products, and the forms they use.
Most-used forms
| Form | Products |
|---|---|
| Schizochytrium sp. (DHA and EPA rich) | 144 |
| Algal Oil | 42 |
| Schizochytrium sp. | 13 |
| Schizochytrium sp. (algal) | 7 |
| Schizochytrium sp. (DHA and EPA) | 3 |
| Schizochytrium sp. (algae) | 3 |
Regulatory & positioning
| Botanical source | Schizochytrium sp. |
|---|---|
| Novel food status | — |
| EFSA authorized health claims | None authorized |
| Marketed categories (observed) | brain health, heart health |
No EFSA-authorized health claim exists for Schizochytrium, yet brands market it for brain health, heart health — the gap between claim and positioning is itself a competitive signal.
Where Schizochytrium shows up
Across the ad channels and marketplaces RavenBI tracks.
See the ads, listings and shops behind these numbers →
What is Schizochytrium?
Schizochytrium (Schizochytrium sp.) is a microalgae-derived source of omega-3 fatty acids, primarily rich in docosahexaenoic acid (DHA). It is classified as a marine-sourced fatty acid ingredient used in dietary supplements. Schizochytrium is commonly included in formulations marketed for brain health and heart health, often as a plant-based alternative to fish oil. Its use extends to various supplement formats including capsules, softgels, and functional foods, catering to consumers seeking vegetarian or vegan omega-3 options.
This overview was generated with AI from public information and RavenBI's classification. Informational only, not medical advice.
30,000+ ingredients tracked across the EU + US · Live competitor ads, prices and product claims · Spot under-served demand in each market before rivals do.
Start free trial — full access